{
  "guideline": {
    "id": "PA166104870",
    "name": "Annotation of FDA Label for pimozide and CYP2D6",
    "source": "FDA",
    "version": 29,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166104870",
    "relatedChemicals": [
      {
        "id": "PA450965",
        "name": "pimozide",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166309021",
      "name": "Recommendation Annotation PA166309021",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450965",
          "name": "pimozide",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452198040,
        "html": "<p>&quot;At doses above 4 mg/day, CYP2D6 genotyping should be performed. In poor CYP2D6 metabolizers, ORAP [pimozide] doses should not exceed 4 mg/day, and doses should not be increased earlier than 14 days.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312148",
      "name": "Recommendation Annotation PA166312148",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450965",
          "name": "pimozide",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216387,
        "html": "<p>&quot;At doses above 0.05 mg/kg/day, CYP2D6 genotyping should be performed. In poor CYP2D6 metabolizers, ORAP [pimozide] doses should not exceed 0.05 mg/kg/day, and doses should not be increased earlier than 14 days.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "0.0"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product ORAP (Pimozide), NDA017473, Teva Select Brands",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=017473"
    }
  ],
  "version": "2024-02-29-20-19"
}